Systemic immune-inflammation index is associated with clinical outcome of acute ischemic stroke patients after intravenous thrombolysis treatment - Zhou, Yuanfeng; Yang, Qian; Zhou, Zhangming; Yang, Xin; Zheng, Danni; He, Zhongchun; Liu, Yizhou; Xu, Tianzhu; Yin, Ying; Wei, Wenhui; Si, Chunli; Zhang, Bozhi; et al. (PloS one, 2025)
Keywords: Administration, Intravenous; Aged; Aged, 80 and over; Biology and Life Sciences; Blood; Blood Platelets; Brain; Brain Edema; Brain Ischemia - drug therapy; Brain Ischemia - immunology; Brain research; Care and treatment; Clinical outcomes; Edema; Female; Hemorrhage; Humans; Inflammation; Inflammation - immunology; Intravenous administration; Intravenous therapy; Ischemia; Ischemic Stroke - drug therapy; Ischemic Stroke - immunology; Laboratories; Leukocytes (neutrophilic); Lymphocytes; Magnetic resonance imaging; Male; Medical examination; Medical prognosis; Medicine and Health Sciences; Middle Aged; Neutrophils; Normal distribution; Patient outcomes; Patients; Prognosis; Regression analysis; Retrospective Studies; ROC Curve; Sensitivity; Statistical analysis; Stroke; Stroke patients; Thrombolysis; Thrombolytic Therapy; Treatment Outcome; Tumors; China